Zhongyang Lu

Dr. Zhongyang Lu

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in Comprehensive Psychoneuroendocrinology
Verified
Journal Article
Open access
ZLZhongyang Lu
Zhongyang Lu
SLShufeng Liu
Shufeng Liu
MLMaria F. Lopes-Virella
Maria F. Lopes-Virella
ZWZhewu Wang
Zhewu Wang
Growing evidence indicates that disturbances in the inflammatory response system can have deleterious effects on neuronal function and mental health. While the correlation between elevated peripheral inflammatory markers and psychiatric disorders are well documented, the exact molecular and neuronal mechanism underlying the connection between activated inflammation and neuropsychiatric behaviour remain elusive. Microglia activation is the key interface between neuro-inflammation and manifestation of psychiatric symptoms. Microglia are immunocompetent cells in the central nervous system (CNS) which are primarily involved in the response to inflammatory stimulation and are widely used to study neuroinflammation and test anti-inflammatory chemicals. In the brain, activated microglia play very important roles during neuroinflammation and neurodegeneration. Both stress-related disorders such as Depression and PTSD, and medical conditions such as metabolic syndrome (Mets) and type 2 diabetes (TD2) are associated with increased levels of both saturated fatty acids (SFAs) and lipopolysaccharide (LPS) in circulation. This work was aimed at determining whether SFA interacts with LPS to activate microglia, thus up-regulating neuroinflammatory processes and, if so which pathways were involved in this process. Our results showed that low-dose LPS and palmitic acid (PA) robustly stimulated the expression of proinflammatory cytokines, and the combination of PA and LPS further upregulated proinflammatory cytokines through MAPK, NFκB and AP-1 signaling pathways in the HMC3-human microglial cell line. In addition, PA stimulated ceramide production via de novo synthesis and sphingomyelin hydrolysis, and the combination of LPS and PA further increased ceramide production. HMC3 co-cultured with macrophage and lymphocyte enhanced LPS and PA induced-inflammatory response more than that in HMC3 alone. These results indicate that LPS interacts with PA to activated microglia; induced neuroinflammatory responses, upregulate proinflammatory cytokine expression via MAPK, NFκB, and AP-1 signaling pathways, and induced sphingolipid metabolism in HMC3. These observations suggest that inhibiting microglia activation and reducing LPS and PA-induced inflammatory response may be useful in the treatment of neuronal inflammatory diseases.

30 December 2018 in Journal of Periodontal Research
Verified
Journal Article
Open access
PDF file
GLGuang Li
Guang Li
SRSamantha Robles
Samantha Robles
ZLZhongyang Lu
Zhongyang Lu
YLYanchun Li
Yanchun Li
JKJoe W. Krayer
Joe W. Krayer
Yan HuangYan Huang
Yan Huang
Background and objective: Metabolic syndrome (MetS) exacerbates periodontitis. Since saturated fatty acid (SFA) is increased in MetS and enhances lipopolysaccharide (LPS)‐induced proinflammatory cytokine expression in macrophages, it has been considered to play a role in MetS‐exacerbated periodontitis. However, it remains unknown how fatty acid receptors, which mediate the interaction of cells with SFA and uptake of SFA, are expressed and regulated in the periodontal tissue. In this study, we tested our hypothesis that the periodontal expression of fatty acid receptors GPR40 and CD36 is increased in patients with both MetS and periodontitis. We also determined the effect of SFA and LPS on GPR40 and CD36 expression in vitro.Material and methods: Periodontal tissue specimens were collected from 11 participants without MetS and periodontitis, 12 participants with MetS, 11 participants with periodontitis, and 14 participants with both MetS and periodontitis after surgeries. The tissues were processed, and GPR40 and CD36 were detected by immunohistochemistry. Furthermore, cultured macrophages and gingival fibroblasts were treated with LPS, palmitate, a major SFA, or LPS plus palmitate and the expression of GPR40 and CD36 was then quantified.Results: Analysis of clinical data showed that age, smoker, gender, and race/ethnicity were not significantly different among 4 groups. Immunohistochemistry showed that GPR40 and CD36 were expressed by epithelial cells, fibroblasts, and immune cells. Quantitative data showed that GPR40 expression is increased in patients with periodontitis, MetS, or both periodontitis and MetS while CD36 expression is increased only in patients with both periodontitis and MetS. The in vitro studies showed that the expression of GPR40 and CD36 in macrophages and fibroblasts was upregulated by the combination of LPS and palmitate.Conclusion: Periodontal expression of GPR40 and CD36 was upregulated in patients with both MetS and periodontitis, and GPR40 and CD36 in macrophages and fibroblasts were upregulated in vitro by the combination of LPS and palmitate, suggesting that GPR40 and CD36 may be involved in MetS‐exacerbated periodontitis.

Verified
Journal Article
Open access
PDF file
ZLZhongyang Lu
Zhongyang Lu
SLShufeng Liu
Shufeng Liu
MFMaria Gabriela Morales France
Maria Gabriela Morales France
AWAndy Whitlock
Andy Whitlock
RRRam Ramkumar
Ram Ramkumar
HRHema Ramkumar
Hema Ramkumar
Dry age-related macular degeneration (AMD) is a leading cause of vision loss in individuals over 50, yet no approved therapies exist for early or intermediate stages of the disease. Oxidative stress is a central driver of retinal degeneration in AMD, and sodium iodate (NaIO3)-induced injury serves as a well-characterized model of oxidative damage to the retinal pigment epithelium (RPE) and photoreceptors. BMI1, a poly-comb group protein involved in DNA repair, mitochondrial function, and cellular renewal, has emerged as a promising therapeutic target for retinal neuroprotection. We evaluated the efficacy of AAV-mediated BMI1 gene delivery in murine models using two administration routes: subretinal (SR) and suprachoroidal (SC). AAV5.BMI1 (1 × 109 vg/eye) was delivered SR in Balb/c mice and evaluated at 4 and 15 weeks post-injection. AAV8.BMI1 (5 × 109 or 1 × 1010 vg/eye) was administered SC in C57BL/6 mice and assessed at 4 weeks. Control groups received BSS or AAV8.stuffer. Following NaIO3 exposure, retinal structure and function were analyzed by optical coherence tomography (OCT), electroretinography (ERG), histology, and molecular assays. SC delivery of AAV8.BMI1 achieved the highest levels of retinal BMI1 expression with no evidence of local or systemic toxicity. Treated eyes showed dose-dependent preservation of outer nuclear layer (ONL) thickness and significantly improved ERG responses indicating structural and functional protection. These findings support SC AAV.BMI1 gene therapy as a promising, minimally invasive, and translatable approach for early intervention in intermediate AMD.

9 October 2024 in Cells
Verified
Journal Article
Open access
PDF file
ZLZhongyang Lu
Zhongyang Lu
MMMaria G. Morales
Maria G. Morales
SLShufeng Liu
Shufeng Liu
HRHema Ramkumar
Hema Ramkumar
BMI1, also known as B lymphoma Mo-MLV insertion region 1, is a protein in the Polycomb group that is implicated in various cellular processes, including stem cell self-renewal and the regulation of cellular senescence. BMI1 plays a role in the regulation of retinal progenitor cells and the renewal of adult neuronal cells. However, the presence, location, and quantification of BMI1 in the adult human eye have never previously been reported. In this study, we collected 45 frozen globes from eye banks, and ocular tissues were dissected. Protein was quantified by utilizing a custom electrochemiluminescence (ECL) assay developed to quantify the BMI1 protein. BMI1 was found in all ocular tissues at the following levels: the retina (1483.6 ± 191.7 pg/mL) and the RPE (296.4 ± 78.1 pg/mL). BMI1 expression was noted ubiquitously in the GCL (ganglion cell layer), the INL (inner nuclear layer), the ONL (outer nuclear layer), and the RPE (retinal pigment epithelium) via immunofluorescence, with higher levels in the inner than in the outer retinal layers and the RPE. These data confirm that BMI1 is expressed in the human retina. Further studies will illuminate the role that BMI1 plays in ocular cells. BMI1 levels are lower in aged retinas, possibly reflecting changes in retinal somatic and stem cell maintenance and disease susceptibility.

1 May 2013 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
ZLZhongyang Lu
Zhongyang Lu
YLYanchun Li
Yanchun Li
JJJunfei Jin
Junfei Jin
XZXiaoming Zhang
Xiaoming Zhang
Yan HuangYan Huang
Yan Huang
Host inflammatory response mediated by toll-like receptor (TLR)4, a pattern recognition receptor for lipopolysaccharide (LPS), plays an important role in cardiovascular complication of diabetes. Although it is known that patients with type 2 diabetes or/and obesity have increased plasma free fatty acids (FAs), and saturated FAs such as palmitic acid (PA) increase host inflammatory response, the interaction between saturated FAs and LPS-elicited TLR4 signaling has not been well elucidated. Since it is known that neovascularization in advanced atherosclerotic plaques contributes to plaque destabilization, we investigated the mechanism whereby PA interacts with LPS for pro-inflammatory gene expression in cardiac microvascular (MIC) endothelial cells (ECs). We found that while LPS at 5 ng/ml stimulated a robust interleukin (IL)-6 secretion in cardiac MIC ECs, 100 μM of PA further augmented the stimulation by more than 2-fold (Control, 4.4; LPS, 41.3, PA, 6.0, LPS+PA, 89.0 ng/ml). Besides IL-6, PA also enhanced the stimulatory effect of LPS on tumor necrosis factor (TNF)α (Control, 2.6; LPS, 38.5, PA, 13.8, LPS+PA, 58.0 pg/ml). Time course study showed that IL-6 expression induced by LPS peaked at 4 h and dropped sharply after the peak. In contrast, addition of PA to LPS delayed the peak to 8 h and stimulated a second peak at 24 h after a transient drop at 12 h. Consistently, quantification of IL-6 in medium showed that IL-6 level in culture medium of cells treated by LPS alone plateaued at 8 h, but addition of PA to LPS led to a continuous liner increase in IL-6 in culture medium up to 48 h. Our further investigation showed that PA and LPS had a synergistic effect on the production of total ceramides and, in particular, C16 ceramide. The involvement of the synergistic effect of LPS and PA on ceramide production in IL-6 upregulation was indicated by the findings that myriocin and fumonisin B1, the inhibitors of ceramide de novo synthesis, and GW4869, an inhibitor of sphingomyelin hydrolysis, reduced IL-6 secretion by cells treated with LPS and PA significantly. Taken together, this study has demonstrated that PA enhances the stimulatory effect of LPS on IL-6 expression in cardiac MIC ECs by increasing ceramide production via both de novo synthesis and sphingomyelin hydrolysis.